Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)
Financial Results:
Biocon Ltd reported Revenues for Q1FY24 of ₹3,423.00 Crores up from ₹2,140.00 Crore year on year, a rise of 59.95%.
Total Expenses for Q1FY24 of ₹3,332.00 Crores up from ₹2,021.00 Crores year on year, a rise of 64.87%.
Consolidated Net Profit of ₹149.00 Crores down 10.78% from ₹167.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹0.84, down 30.00% from ₹1.20 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.